Intersect ENT manufactures and sells PROPEL®, a spring-like sinus stent coated with an anti-inflammatory medication placed following sinus surgery. After about 30 days, it completely dissolves.
PROPEL helps improve the results of surgery by decreasing the chance of post-surgical scarring and inflammation as well as reduces the need for oral steroids.
Chronic sinusitis can be challenging to diagnose and patients often don’t respond to medications.
The company believed there was an opportunity to educate the target patient population about a new treatment that could provide better and longer-term relief compared to other options.
To educate the patient audience and drive them to search for an ENT offering the PROPEL sinus stent, Grey Matter Marketing delivered the following:
"The Grey Matter Team was an enormous help with digital marketing/direct-to-consumer strategy and execution. From the initial in-person meetings to diving deep into analytics, to conducting qualitative and quantitative research, to the final campaign—everything was spot on and accomplished at a scale to fit our budget. We get compliments all the time about our blog posts and depth of relevant patient content they developed. Plus, working with the GMM team feels like working with a supercharged and fun extension of your own team!"
~ Vasey Hargreaves, Director of Marketing